Retrospective analysis of the course and outcomes of juvenile arthritis in adult patients


Cite item

Full Text

Abstract

Aim. To assess the course and outcomes, functional and social status in long ill patients with juvenile arthritis (JA).
Subjects and methods. The study included 213 patients aged 16 to 60 years (mean age 23.9 ± 6.5 years) with JA with its duration of 10 to 53 years (mean 17.4 ± 6.8 years). Ninety-seven patients were examined at the Institute of Rheumatology; the others filled in the social status and health assessment questionnaires (HAQ).
Results. Polyarthritis and oligoarthritis were found in 72.9 and 17.7%, respectively; no articular changes were seen in 9.4%. Systemic signs were noted in 3.1%. A fourth of the patients developed uveitis. Articular functional limitations were minimal or absent (functional class (FC) I, II and HAQ = 0-1.0 score) in 71-81.2%; 18.8-29% needed assistance by other persons (FC III, IV and HAQ = 2.1-3.0 scores). The FC correlated with the clinico-laboratory indicators. Mild or moderate JA persisted in 87.8% of the patients. A third of the patients were found to have erosions; 31.9% presented with ankylosis; 27.8% had aseptic necrosis of predominantly the femoral head. The health status was appraised as good or very good, satisfactory, or bad by 43.3, 39.8, and 16.9% of the patients, respectively. 78.9% of the patients worked or studied; 48.2% graduated from or continued their education at the institute; 31.7% were married; 46 patients had children.
Conclusion. In most adult patients with childhood-onset JA, the activity of the disease reduced; a good functional outcome was noted. The health status made it possible to obtain profession and to be adapted to routine life and social environment. The patients with the severer course and outcome of the disease with the formation of significant functional limitations needed treatment and further medical follow-up.

About the authors

Svetlana Olegovna Salugina

S O Salugina

Research Institute of Rheumatology, Russian Academy of Medical Sciences

Research Institute of Rheumatology, Russian Academy of Medical Sciences

References

  1. Prahalad S., Passo M. H. Long-term outcome among patients with JRA. Front. Biosci. 1998; 21 (3): 13-22.
  2. Gare B. A., Fasth A. The natural history of juvenile chronic arthritis: a population based cohort study. I. Onset and disease process. J. Rheumatol. 1995; 22: 295-307.
  3. Flato B., Aasland A., Odd V. et al. Outcome and predictive factors in JRA and juvenile spondiloarthropathy. J. Rheumatol. 1998; 25: 366-375.
  4. Guillaume S., Prieur A. M., Coste J. et al. Long-term outcome and prognosis in oligoarticular-onset juvenile idiopathic arthritis. Arthr. Rheum. 2000; 43(8): 1858-1865.
  5. Minden K., Niewerth M., Listing J. et al. Long-term outcome in patients with juvenile idiopathic arthritis. Arthr. and Rheum. 2002; 46: 2392-2401.
  6. Oen K. Long-term outcomes and predictors of outcomes for patients with juvenile idiopathic arthritis. Best Pract. Res. Clin. Rheumatol. 2002; 16 (3): 347-360.
  7. Foster H. E., Marshall N., Myers A. et al. Outcome in adults with juvenile idiopathic arthritis: a quality of life study. Arthr. and Rheum. 2003; 48 (3): 767-775.
  8. Salliere D., Segond P., Bisson M. Evolution a long terme des arthritis chroniques juveniles. Sem. Höp. Paris 1981; 57 (25/ 28): 1155-1160.
  9. David J., Cooper C., Hickey L. et al. The functional and psychological outcomes of JCA into young adulthood. Br. J. Rheumatol. 1994; 33: 876-881.
  10. Peterson L. S., Mason T., Nelson A. M. et al. Psychosocial outcomes and health status of adults who have had JRA. Arthr. and Rheum. 1997; 40 (12): 2235-2240.
  11. Ruperto N., Levinson J. E., Ravelli A. et al. Long-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. I. Outcome status. J. Rheumatol. 1997; 24 (5): 945-951.
  12. Spiegel L. R., Schneider R., Lang B. A. et al. Early predictors of poor functional outcome in systemic-onset JRA. A multicenter cohort study. Arthr. and. Rheum. 2000; 43: 2402-2409.
  13. Oen K., Reed M., Malleson P. N. et al. Radiologic outcome and its relationship to functional disability in JRA. J. Rheumatol. 2003; 30 (4): 832-840.
  14. Adib N., Silman A., Thomson W. Outcome following onset of juvenile idiopathic inflammatory arthritis: I. Frequency of different outcomes. J. Rheumatol. 2005; 44 (8): 995-1001.
  15. Packham J. C., Hall M. A. Long-term follow-up of 246 adults with JIA: functional outcome. J. Rheumatol. 2002; 41 (12): 1428-1435.
  16. Flato B., Lien G., Smerdel A. et al. Prognostic factors in juvenile rheumatoid arthritis: a case-control study revealing early predictors and outcome after 14.9 years. J. Rheumatol. 2003; 30 (2): 386-393.
  17. Koivuniemi R., Leirisalo-Repo M. Juvenile chronic arthritis in adult life: a study of long-term outcome in patients with juvenile chronic arthritis or adult rheumatoid arthritis. Clin. Rheumatol. 1999; 18 (3): 220-226.
  18. Oen K., Malleson P. N., Cabral D. A. et al. Early predictors of longterm outcome in patients with IRA: subset-specific correlations. J. Rheumatol. 2003; 30: 585-593.
  19. Martini A. Are the number of joints involved or the presence of psoriasis still useful tools to identify homogeneous entities in JIA? J. Rheumatol. 2003; 30: 1900-1903.
  20. Petty R. E. Classification of childhood arthritis: a work in progress. Balliere's Clin. Rheum. 1998; 12 (2): 181-190.
  21. Ravelli A. Toward an understanding of the long-term outcome of juvenile idiopathic arthritis. Clin. Exp. Rheum. 2004; 22: 271-275.
  22. Woo P., Tessel E. M., van der Net J. et al. Outcome status in children with sustained polyarticular and systemic juvenile idiopathic arthritis: Letter to the Editor. J. Rheumatol. 2001; 40: 225-226.
  23. Gare B. A., Fasth A. The natural history of juvenile chronic arthritis: a population based cohort study. II. Outcome. J. Rheumatol. 1995; 22: 308-319.
  24. Fantini F., Gerloni V., Gattinara M. et al. Remission in juvenile chronic arthritis: a cohort study of 683 consecutive cases with a mean 10 year followup. J. Rheumatol. 2003; 30 (3): 579- 584.
  25. Fernandes T. A., Corrente I. E., Magalhaes C. S. Remission status follow-up in children with juvenile idiopathic arthritis. J. Pediatr. (Rio J.) 2007; 83 (2): 141-148.
  26. Wallace C. A., Ruperto N., Giannini E. H. Childhood Arthritis and Rheumatology Research Alliance; Pediatric Rheumatology International Trials Organization; Pediatric Rheumatology Collaborative Study Group. Preliminary criteria for clinical remission for select categories of juvenile idiopathic artritis. J. Rheumatol. 2004; 31: 2290-2294.
  27. Zak M., Pedersen F. K. Juvenile chronic arthritis into adulthood: a long-term follow-up study. Rheumatology (Oxf.) 2000; 39 (2): 198-204.
  28. Minden K., Kiessling U., Listing J. et al. Prognosis of patients with juvenile chronic arthritis and juvenile spondyloarthropathy. J. Rheumatol. 2000; 27 (9): 2256-2263.
  29. Kanski J. J. Uveitis in JCA: incidence, clinical features and prognosis. Eye 1988; 2: 641-645.
  30. Carvounis P. E., Herman D. C., Cha S. et al. Incidence and outcomes of uveitis in juvenile rheumatoid arthritis, a synthesis of the literature. Graefes Arch. Clin. Exp. Ophthalmol. 2006; 244: 281-290.
  31. Салугина С. О. Клинико-лабораторная характеристика ювенильного ревматоидного артрита с поражением глаз: Автореф. дис. ... канд. мед. наук. М.; 2001.
  32. Schaller J. J., Kupfer C., Wedgwood R. J. Iridocyclitis in JRA. Pediatrics 1969; 44: 92-100.
  33. Chylack L. T. Jr. The ocular manifestations of JRA. Arthr. and Rheum. 1977; 20: 217-223.
  34. Giannini E. H., Malagon C. N., Van Kerckhove C. et al. Longitudinal analysis of HLA associated risks for iridocyclitis in JRA. J. Rheumatol. 1991; 18: 1394-1397.
  35. Rosenberg A. M. Uveitis associated with JRA. Semin. Arthr. Rheum. 1987; 16: 158-173.
  36. Chalom E. G., Goldsmith D. P., Koehler M. A. et al. Prevalence and outcome of uveitis in a regional cohort of patients with JRA. J. Rheumatol. 1997; 24: 2031-2034.
  37. Bowyer S. L., Roettcher P. A., Higgins G. C. et al. Health status of patients with JRA at 1 and 5 years after diagnosis. J. Rheumatol. 2003; 30: 394-400.
  38. Oen K., Malleson P. N., Cabral D. A. et al. Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort. J. Rheumatol. 2002; 29 (9): 1989-1999.
  39. Calabro J. J., Marchesano J. M., Parrino G. R. JRA: Long-term management and prognosis. J. Musculo. Med. 1989; 6: 17-32.
  40. Dequeker J., Mardjuadi A. Prognostic factors in JCA. J. Rheumatol. 1982; 9: 909-915.
  41. Hanson V., Kornreich H., Dernstein B. et al. Prognosis of JRA. Arthr. Rheum. 1977; 20: 279-284.
  42. Hill R. H., Herserin A., Walters K. Juvenile rheumatoid arthritis: follow-up into adulthood - medical, sexual and social status. Can. Med. Assoc. J. 1976; 114 (9): 790-795.
  43. Miller J. J., Spitz P. W., Simpson U. et al. The social function of young adults who had arthritis in childhood. J. Pediatr. 1982; 100: 378-382.
  44. King K., Hanson V. Psychosocial aspects of JRA. Pediatr. Clin. N. Am. 1986; 33 (5): 1221-1237.
  45. Larbre J. P., Duquesne A., Gheta D. et al. Collaboration in long term follow-up of juvenile idiopathic arthritis. In: 15th European Paediatric Rheumatology Society Congress, London, UK, 14-17 Sept. 2008: Abstract Book: London; 2008. 82.
  46. Логинова Е. Ю., Фоломеева О. М. Клинико-функциональные психосоциальные исходы и трудоспособность при ювенильном идиопатическом артрите у взрослых пациентов. Науч.-практ. ревматол. 2004; 2: 53-58.
  47. Российский статистический сборник. М.; 2002.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2010 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies